Investigating how mTOR activation affects blood vessel remodeling in lung disease.

Role of mTOR Hyperactivation in Pulmonary Vascular Remodeling

NIH-funded research University of Pennsylvania · NIH-10865916

This study is looking at how a specific pathway in our cells might affect blood vessel changes in people with pulmonary hypertension, with the hope of finding new ways to help improve treatments for this condition.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania NIH-funded
Lab location1 site (Philadelphia, United States)
Project IDNIH-10865916 on NIH RePORTER

What this research studies

This research focuses on pulmonary hypertension, a serious lung condition that leads to changes in blood vessel structure and function. The study aims to understand the role of the mTOR signaling pathway in these changes, particularly how its hyperactivation in certain cells can influence the behavior of blood vessel cells. By examining these cellular interactions, the research seeks to uncover new therapeutic targets that could improve treatment options for patients with pulmonary hypertension.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with pulmonary hypertension, particularly those with pulmonary arterial hypertension.

Not a fit: Patients with pulmonary hypertension caused by factors unrelated to mTOR signaling may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that effectively target the underlying mechanisms of pulmonary hypertension, improving patient outcomes.

How similar studies have performed: Previous research has shown promising results in targeting the mTOR pathway for various diseases, suggesting potential success for this approach in pulmonary hypertension.

Where this research is happening

Philadelphia, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Bourneville DiseaseBourneville syndromeBourneville-Brissaud diseaseBourneville-Pringle syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.